Find a Lawyer

Partner

Yong Bai

Yong Bai specialises in Antitrust and Competition issues and has more than 10 years of experience advising Chinese and multinational corporations on business investment, regulatory matters and investigations across a range of industries.

Yong's deal experience includes Pfizer's US$160 billion merger with Allergan; inbound investments into China for multinationals like Coca-Cola and private equity firms; and outbound transactions by Chinese investors such as COFCO's acquisitions of Noble Agri and Nidera. Yong has worked in the London and Brussels offices, and prior to joining the firm, he worked for the PRC's Ministry of Commerce. He received his Bachelor of Laws from Shanghai International Studies University and his LLM from Tsinghua Law School and Columbia Law School. He is fluent in English and Mandarin.

Pfizer on its USD 160 billion merger with Allergan. The transaction was the world's largest ever merger in terms of value to date.
GE on its USD 32 billion merger of its oil and gas business with Baker Hughes International.
The Coca-Cola Company on its restructuring of its bottling business in China through a series of inter-related transactions with its partners, Swire Beverages Holdings Limited and COFCO Coca-Cola Beverages limited
COFCO Corporation on its acquisition of Noble Agri and Nidera – coordinating antitrust and foreign investment filings in 15 jurisdictions in total, including China, the EU and the US